Literature DB >> 12686088

The evolution of influenza surveillance in Europe and prospects for the next 10 years.

D M Fleming1, J van der Velden, W J Paget.   

Abstract

This report traces the evolution of surveillance programmes for influenza in the United Kingdom and countries of western Europe since the World Health Organisation (WHO) resolution to establish an international influenza reference centre in 1947. The introduction of clinical surveillance schemes in the late 1960s and their gradual integration with laboratory-based surveillance is described, with particular emphasis on the need for integrated surveillance based on population-specific denominators. The function of the European Influenza Surveillance Scheme (EISS), its work programme in the last 5 years, and the likely direction of future developments is outlined. The report advocates the EISS model of influenza surveillance, which involves the integrated collection of clinical and laboratory data in the same population using sentinel practitioners.

Mesh:

Year:  2003        PMID: 12686088     DOI: 10.1016/s0264-410x(03)00066-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Seroconversion and immunogenicity evaluation of seasonal influenza vaccine in mice model.

Authors:  Arti Bharmoria; Vipin Behari Vaish; K R Mani
Journal:  Virusdisease       Date:  2016-08-17

2.  Modeling Competing Infectious Pathogens from a Bayesian Perspective: Application to Influenza Studies with Incomplete Laboratory Results.

Authors:  Yang Yang; M Elizabeth Halloran; Michael J Daniels; Ira M Longini; Donald S Burke; Derek A T Cummings
Journal:  J Am Stat Assoc       Date:  2010-12       Impact factor: 5.033

Review 3.  Disease mapping and innovation: A history from wood-block prints to Web 3.0.

Authors:  Tom Koch
Journal:  Patterns (N Y)       Date:  2022-06-10

4.  The emergence and consistency of influenza strains causing influenza like illness in Himachal Pradesh, India.

Authors:  Arti Bharmoria; Vipin Behari Vaish; Ashish Chaurasia; A K Tahlan
Journal:  Virusdisease       Date:  2016-04-07

5.  Surveillance recommendations based on an exploratory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System.

Authors:  Tamara J Meerhoff; Douglas Fleming; Ann Smith; Anne Mosnier; Arianne B van Gageldonk-Lafeber; W John Paget
Journal:  BMC Infect Dis       Date:  2006-08-09       Impact factor: 3.090

6.  Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Authors:  Adam Meijer; Angie Lackenby; Olav Hungnes; Bruno Lina; Sylvie van-der-Werf; Brunhilde Schweiger; Matthias Opp; John Paget; Jan van-de-Kassteele; Alan Hay; Maria Zambon
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

7.  Predicting pneumonia and influenza mortality from morbidity data.

Authors:  Lise Denoeud; Clément Turbelin; Séverine Ansart; Alain-Jacques Valleron; Antoine Flahault; Fabrice Carrat
Journal:  PLoS One       Date:  2007-05-23       Impact factor: 3.240

8.  Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries.

Authors:  J Beauté; P Zucs; N Korsun; K Bragstad; V Enouf; A Kossyvakis; A Griškevičius; C M Olinger; A Meijer; R Guiomar; K Prosenc; E Staroňová; C Delgado; M Brytting; E Broberg
Journal:  Epidemiol Infect       Date:  2015-02-04       Impact factor: 4.434

9.  Reassessing Google Flu Trends data for detection of seasonal and pandemic influenza: a comparative epidemiological study at three geographic scales.

Authors:  Donald R Olson; Kevin J Konty; Marc Paladini; Cecile Viboud; Lone Simonsen
Journal:  PLoS Comput Biol       Date:  2013-10-17       Impact factor: 4.475

10.  Validity and timeliness of syndromic influenza surveillance during the autumn/winter wave of A (H1N1) influenza 2009: results of emergency medical dispatch, ambulance and emergency department data from three European regions.

Authors:  Nicole Rosenkötter; Alexandra Ziemann; Luis Garcia-Castrillo Riesgo; Jean Bernard Gillet; Gernot Vergeiner; Thomas Krafft; Helmut Brand
Journal:  BMC Public Health       Date:  2013-10-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.